CIK 0001850838
OMGA Omega Therapeutics, Inc.
Insider trading from SEC Form 4. Last filing Dec 5, 2024.
Omega Therapeutics, Inc. (OMGA) has 3 SEC Form 4 filings on file from 3 insiders, the latest filed on Dec 5, 2024. No insider bought or sold on the open market in the last 90 days; rows filed in that time are grants, exercises, tax withholding and other transactions that carry no view on the price.
1 Form 144 notice of planned sales is on file, the latest filed Feb 5, 2025.
Last 90 days
Signals
Open-market buys and sells at Omega Therapeutics, Inc., scored.
Planned sales
Form 144 notices filed before a sale of restricted or control stock, newest first. The sale itself usually reaches a Form 4 within days. All planned sales
| Filed | Seller | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Feb 5, 2025 | Richard Young Former board member within 90 days | 550,000 0.99% of outstanding | $100k | Feb 5, 2025 | none |
Transactions
Every row filed, 3 in all.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 3, 2024 | Ravi Mehrotra director | AGrant or award Stock Option (Right to Buy)derivative | +50,000 | $0.00 | $0 | 50,000 | Dec 5, 2024 |
| Nov 22, 2024 | Jennifer Ann Nelson Chief Scientific Officer | AGrant or award Stock Option (Right to Buy)derivative | +110,000 | $0.00 | $0 | 110,000 | Nov 26, 2024 |
| Nov 15, 2024 | Kaan Certel See Remarks | AGrant or award Stock Option (Right to Buy)derivative | +340,000 | $0.00 | $0 | 340,000 | Nov 15, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- Kaan CertelSee Remarks
- Ravi Mehrotradirector
- Jennifer Ann NelsonChief Scientific Officer
Questions about OMGA
Answered from the filings on this page, as of the latest one.
Are insiders buying OMGA?
No. In the last 90 days no insider at Omega Therapeutics, Inc. bought or sold shares on the open market according to SEC Form 4 filings. The rows on file from that period are grants, exercises, tax withholding or other transactions, which carry no view on the price.
Who was the last insider to trade OMGA on the open market?
No open-market trade has been scored at Omega Therapeutics, Inc.. The latest Form 4 on file was filed on Dec 5, 2024 and holds grants, exercises or other rows that are not market trades.
How many insiders file Form 4 at Omega Therapeutics, Inc.?
3 people have filed a Form 4 at Omega Therapeutics, Inc., among them Kaan Certel (See Remarks), Ravi Mehrotra (director), Jennifer Ann Nelson (Chief Scientific Officer). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.